Top Injectable Manufacturer in Solomon Islands – Reliable Pharmaceutical Solutions
Last Updated: September 12, 2026
TL;DR: Solomon Islands has no medicines register. The Pharmacy and Poisons Act has been in force since 1941 and licenses sellers and premises, not products, so there is no dossier to file. Section 43 makes the British Pharmacopoeia the standard of quality for every medicine sold. What actually binds a consignment is the importer's own licence, the Ministry's tender, and the donor rules attached to malaria and tuberculosis money.
Key Takeaways
There is no product registration system. The Act creates registers of pharmacists and of premises, and none for medicines. Anyone quoting a Solomon Islands registration timeline is describing something that does not exist.
Section 43 makes the British Pharmacopoeia the standard of quality and composition for all medicines, and it was re-enacted in 1978 rather than merely inherited. The Indian Pharmacopoeia is named nowhere in the Act.
Import lawfulness turns on the scope of the importer's own licence, not on the product and not on the foreign plant. No CPP, GMP certificate or overseas inspection appears anywhere in the statute.
For Global Fund-financed artesunate and tuberculosis injectables, WHO prequalification or an Expert Review Panel recommendation is the route. For everything else the policy defers to the standard of the country of use.
Introduction: What an Injectable Manufacturer in Solomon Islands Has to Prove
Every market in this series opens with the same question — does the country name the foreign regulators whose decisions it will lean on, and is India's CDSCO among them? Solomon Islands answers by not asking the question at all. There is no reliance list, and there is no product register for a reliance list to feed. The Pharmacy and Poisons Act, in force since 28 July 1941 and consolidated in the 1996 revised edition, creates a register of pharmacists and a register of premises. It creates nothing for medicines.
That reframes the whole exercise. This is not a dossier market, and a supplier who offers you a registration timeline for it is describing a process that does not exist. Section 49 makes an import unlawful if the importer is not entitled under their licence to sell the thing being imported. The gate sits on the buyer, not on the product.
What Sets a World-Class Injectable Manufacturer in Solomon Islands Apart
Section 43 provides that the British Pharmacopoeia, in the edition for the time being in force, is the standard of quality or composition for all drugs and medicines. That is exclusive drafting — the standard, for all medicines — and it carries a detail worth noticing, because the section was re-enacted in 1978, the year of independence. Indian sterile plants routinely release to BP monographs, so this aligns well; an IP-only specification is the weak flank.
The second thing to understand is where quality is actually policed, which is procurement rather than law. Public medicines move through the National Medical Store in Honiara to eighteen second-level stores and on to more than 350 service delivery points, free at the point of use. In 2023 the Ministry put bidding onto a digital platform and made expiry information and minimum delivery periods mandatory bid conditions. Those tender terms, not the 1941 statute, are where a manufacturer's certifications actually get read.
Quality Systems Behind Every Sterile Injectable We Ship to Solomon Islands
Farbe Firma manufactures under WHO-GMP certification in ISO Class 5 filling environments, with validated aseptic process simulation, environmental monitoring and container-closure integrity testing. Release testing runs on HPLC and GC against USP, BP, IP or EP monographs, with LAL for bacterial endotoxins and Karl Fischer for moisture in lyophilised vials. Stability follows ICH Q1A with Q1B photostability. Dossiers are built in CTD structure with ACTD available — not because Solomon Islands asks for one, but because a tender or a donor will.
Two local realities shape the specification more than any rule does. Solomon Islands publishes no national stability condition; the WHO reference table places it at 30°C and 65% relative humidity, and that entry is derived from climate data rather than confirmed by the regulator, so we found no binding requirement and therefore claim none. We hold Zone IVb data because it envelopes that. And the last leg runs by boat, light aircraft and motorbike to clinics often staffed by one nurse, across nine provinces and ninety inhabited islands, which argues for long remaining shelf life far more than for cold chain.
Working out whether Solomon Islands is reachable for your product? Talk to our regulatory team
Why Farbe Firma is the Trusted Injectable Manufacturer in Solomon Islands for Global Buyers
Farbe Firma Pvt Ltd is a WHO-GMP certified sterile injectable manufacturer and CDMO in Gujarat, India, filling under ISO Class 5 conditions and exporting to more than 30 countries. For Solomon Islands we can supply WHO-format GMP and pharmaceutical product certificates, BP-referenced release data and full stability packages for a tender file. What we cannot do is import, and no certificate we hold cures that: every licence in the Act attaches to a local person and local premises. We hold no Solomon Islands licence and recommend no partner we have not verified.
The binding quality gate for part of the portfolio is a donor rule rather than a national one. The Global Fund accepts WHO prequalification, a pre-2015 stringent regulatory authority, a WHO Listed Authority or its Expert Review Panel — and India's CDSCO is none of those for medicines, since WHO lists it for vaccines only. But that gate applies solely to antiretroviral, anti-tuberculosis and antimalarial finished products; for everything else the policy defers to the standard of the country of use. Malaria is why this matters here: WHO recorded 147,145 presumed and confirmed cases in 2023, with 99% of the population living in a high-transmission area, and injectable artesunate has been national policy for severe malaria since 2018.
The financing picture is unusual and easy to misread. Population was 838,645 in 2025; current health expenditure was 5.36% of GDP in 2023 at US$111 per head, putting the national total near US$89 million. Out-of-pocket spending was just 3.16% — among the lowest anywhere — but that figure is partly an artefact of the 33.87% financed externally in the same year, up from 27.37% in 2022. A third of the denominator is donor money, so the low household share is not by itself evidence of financial protection. We will not print a market-size figure: the two customs series we found disagree and both look implausible against US$89 million.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Does Solomon Islands recognise India's CDSCO or Indian regulatory approval?
There is nothing to recognise it with. No instrument names any foreign medicines regulator — not CDSCO, and equally not the TGA, MHRA, US FDA or EMA — because the Act contains no agency-recognition mechanism and no product register. Where CDSCO status does bite is inside Global Fund money, and there it does not qualify.
Is the Indian Pharmacopoeia accepted in Solomon Islands?
Not on any published basis. Section 43 names the British Pharmacopoeia exclusively, as the standard for all drugs and medicines, and the Act's own schedule uses BP and BPC designations throughout. This is not fatal for an Indian supplier, because BP release is standard practice in Indian sterile plants — but an IP-only specification has no statutory footing, and a supplier claiming otherwise is reading something that is not there.
Does a foreign manufacturer need a local partner in Solomon Islands?
Yes, unavoidably. Every authorisation in the Act attaches to a local person or body corporate operating local premises: a Medicine Licence is granted to a licensed storekeeper and names the articles that may be sold, a Poisons Licence covers one place of business, and a body corporate dealing in drugs must trade under a registered pharmacist as superintendent. A foreign manufacturer holds nothing and can hold nothing.
What does registration cost in Solomon Islands, and how long does it take?
Neither question has an answer, and that is the finding rather than a gap. There is no registration, so there is no registration fee and no statutory decision clock anywhere in the Act — the only figures in the statute are legacy amounts that show its age. The Government's own trade portal publishes no medicines procedure at all. Confirm current practice directly with the Ministry of Health and Medical Services.
What actually controls an injectable consignment arriving in Solomon Islands today?
Three things, none of them a product approval. The importer's licence scope, under section 49, which makes the import unlawful if the licence does not cover the article. A discretionary power for the Under Secretary for Health to certify goods to Customs as not to be imported. And a separate Board licence for anything on the poisons list, which for an injectable portfolio notably includes insulin. A pharmacy permit is also reported in practice, though we found no instrument establishing one.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments